Evaluation of a father and son with atypical chronic myeloid leukemia with SETBP1 mutations and a review of the literature

AUTOR(ES)

Wang, L., Du, F., Zhang, H.-M., Wang, H.-X.

FONTE

Braz J Med Biol Res

DATA DE PUBLICAÇÃO

26/05/2015

RESUMO

We report the case of a father and son diagnosed with atypical chronic myeloid leukemia (aCML). Both patients harbored SETBP1 mutations, which are present in 24.3% of aCML patients. Moreover, both shared the variant encoding p.Pro737His, but the aCML severity was greater in the son because of the presence of two other missense mutations causing p.Asp868Asn and p.Ser885Arg alterations. SETBP1 mutations may be associated with an adverse prognosis, so their detection would help in the diagnosis of aCML and the determination of a patient's prognosis.

Documentos Relacionados

• Imatinib resistance: a review of alternative inhibitors in chronic myeloid leukemia
• Cutaneous myeloid sarcoma associated with chronic myeloid leukemia
• Atypical chronic myeloid leukemia with t(9;22)(p24,11.2), a BCR-JAK2 fusion gene
• Evaluation of anemia after long-term treatment with imatinib in chronic myeloid leukemia patients in chronic phase
• Eosinophilic fasciitis in a father and son.